A&S Investment Holding Announces Major €2 Billion Investment in PUREdrip Longevity and Advanced Health Research
HEIDELBERG, GERMANY / ACCESS Newswire / March 10, 2026 /A&S Investment Holding chairman/Ceo Ugur Akkus has announced a landmark strategic investment in the rapidly growing field of longevity and advanced human health research. The company has acquired 80% of the shares of Puredrip Longevity Centers, one of Germany 's leading health and longevity companies.
PureDrip was founded by renowned longevity researcher German Heidelberg and Mainz university Professor Dr. Stefan Stefanovic, Dr. Maximilian Kohler, Dr. Jan Hofmann, and M. Sc. Nemanja Markovic who have developed innovative longevity and preventive health solutions designed to extend human life expectancy and significantly improve long-term health.
As part of this strategic acquisition, A&S Investment Holding and Puredrip will begin global expansion of longevity and healthy aging clinics. The concept will be based on the successful prototype clinic currently operating in Heidelberg, Germany, which will serve as the model for future centers around the world.
Global Expansion of Longevity Clinics
Through this partnership, the companies aim to establish a worldwide network of advanced longevity clinics focusing on preventive medicine, cellular health optimization, and cutting-edge treatments designed to support longer and healthier lives.
The initiative will combine medical innovation, biotechnology, and personalized health strategies to redefine the future of preventive healthcare.
World 's Largest Longevity Research Initiative
In addition to the clinic expansion, A&S Investment Holding and Professor Dr Stefan Stefanovic and Dr Janhofman - a professor affiliated with Heidelberg University - have announced plans to jointly establish one of the world 's largest research centers dedicated to longevity science and human DNA research focus to make human life 250 years
The research program will focus on understanding the biological mechanisms of aging and exploring the potential to significantly extend human lifespan.
The ambitious long-term goal of the initiative is to explore scientific pathways that could allow humans to live dramatically longer - potentially extending the human lifespan toward 250 years while maintaining health and vitality.
$2 Billion Investment Commitment
A&S Investment Holding has allocated $2 billion in funding for the project, which will support both the expansion of global longevity clinics and the establishment of a major research facility.
The research center is planned to be developed in collaboration with international scientists and academic institutions, including teams working alongside Professor Dr Stafan Stefanovic.
The center will likely be located in the United States, with the aim of creating a global hub for longevity science and advanced biomedical research.
Shaping the Future of Human Health
This strategic partnership reflects a growing global interest in longevity science - an emerging field focused not only on extending lifespan but also improving healthspan, enabling people to live longer, healthier, and more productive lives.
Through this initiative, A&S Investment Holding aims to position itself at the forefront of one of the most transformative sectors of the future: the science of longevity NAD+ and human life extension.
Get in touch
+4917680268740
info@puredrip.de
Address: Q6 9, 68161 Mannheim, Germany
SOURCE:PUREdrip
View the original press release on ACCESS Newswire
© 2026 ACCESS Newswire. All Rights Reserved.
